Delårsrapport for perioden 1. januar – 30. september 2023
Bestyrelsen for Tivoli A/S har den 26. oktober 2023 behandlet og godkendt delårsrapporten for perioden 1. januar - 30. september 2023.
Resultatet for perioden 1. januar - 30. september 2023 er i hovedtræk:
- En nettoomsætning på 845,4 mio. kr. mod 773,3 mio. kr. sidste år (+9%).
- Et resultat før af- og nedskrivninger (EBITDA) på 126,0 mio. kr. mod 132,6 mio. kr. sidste år.
- Et resultat før skat på 38,1 mio. kr. mod 41,1 mio. kr. sidste år.
- Et besøgstal på 2.694.000 mod 2.502.000 sidste år (+8%).
De første måneder af 2023 bød på store vedligeholdelses- og forberedelsesarbejder forud for sæsonstart i slutningen af marts og blev efterfulgt af en velbesøgt sommersæson. Sommeren har givet Tivoli og oplevelsesindustrien generelt en række udfordringer; juli måned blev rekordvåd og de to store nærmarkeder, Sverige og Norge, gav, på grund af svækket økonomi og købekraft, markante fald i antallet af gæster. På trods af disse forhold endte gæstetallet for perioden 1. januar - 30. september 2023 på 2.694.000, hvilket, godt hjulpet af syv ekstra åbningsdage, er 8% højere end samme periode sidste år.
”Tivoli har oplevet solid fremgang i forretningen, og sommeren 2023 har givet de bedste resultater i Tivolis historie. Der er fortsat usikkerhed om den makroøkonomiske udvikling og om, hvordan udviklingen i vores nabolande vil påvirke andelen af turister fra de store nærmarkeder resten af året. Tivolis forretning står dog på baggrund af vinterens investeringer, en succesfuld afviklet sommersæson samt en flot åbning af Halloween i Tivoli rustet til en stærk afslutning på 2023 med en velplanlagt julesæson, der bl.a. byder på en ny spektakulær skøjtebane.”, udtaler adm. direktør, Susanne Mørch Koch.
Forventninger til 2023
Tivolis gode start på 2023 er fortsat igennem sommersæsonen, hvor den forbrugsmæssige afmatning har været mindre end forventet. Tivolis senest udmeldte forventning var en omsætning i niveauet 1.150 mio. kr. samt et resultat før skat i niveauet 70-90 mio. kr. Grundet sommerens rekordhøje omsætning og resultater samt forventningerne til resten af året, opjusterer Tivoli nu forventningerne til en omsætning i niveauet 1.200 mio. kr. samt et resultat før skat i niveauet 100 mio. kr.
Med venlig hilsen
Tom Knutzen Susanne Mørch Koch
Bestyrelsesformand Adm. direktør
Kontaktperson: Pressechef, Torben Plank tlf. 22237440 / tpl@tivoli.dk
Vedhæftede filer
- Tivoli AS - Fondsbørsmeddelelse nr 9 - Delårsrapport for perioden 1. januar - 30. september 2023
- Tivoli AS - 3. kvartal 2023
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.
Information om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeddelelser fra GlobeNewswire by notified
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra GlobeNewswire by notified
Dassault Aviation Wins Choiseul “Strategic Company” Award29.11.2023 10:21:57 CET | Press release
Dassault Aviation Wins Choiseul “Strategic Company” Award (Saint-Cloud, November 29, 2023) – Dassault Aviation is particularly proud to have received the 2023 Strategic Company Award as part of the Institut Choiseul’s Sovereignty Initiative. The institute believes that strategic companies represent one of the many facets of national strength. Award recipients are known for their capacity to effectively mobilize resources and know-how, and to provide solutions that meet national priorities. They are a cornerstone of French strategic heritage. Dassault Aviation is an industrial architect and complex systems integrator, a developer of strategic technologies, a major national exporter, a core shareholder of the Thales Group and a vital player in an industrial landscape that includes hundreds of business and service partners. The company is at the core of the French sovereign defense ecosystem. Dassault Aviation is also the only non-American company that manufactures high-end business jets.
Company announcement no 17/2023 Interim Report Q3 202329.11.2023 10:20:00 CET | Press release
Interim Report Q3 2023 EBITDA fixed herd prices (FHP) for Q3 2023 increased to 13.663 mEUR (Q3 2022: 10.463 kEUR), corresponding to an EBITDA margin FHP of 36.3% (Q3 2022: 32.5%). The quarterly EBITDA in Q3 2023 increased by 3.201 kEUR (compared to Q3 2022). Nevertheless, this consist of many parts this quarter: Russia harvest negative with 2,7 mEUR (from 4,1 to 1,5 mEUR) whereas remaining Russian business compensate positive with 3,0 mEUR partly due to FX (cost in EUR lower), Lithuania negative effects from one-off subsidy in Q3 2022 (2,5 mEUR), but combined sales/feed with positive effect of 4.9 mEUR and lower cost levels with 0.5 mEUR driven by utilities. Sales prices combined down, as they in Q3 2023 were 1.59 EUR/kg live weight, down from 1.62 EUR/kg Q2 2022 equal to EUR 0,8m, but EURRUB effects this picture highly as Lithuanian sales prices in EUR is up 23% and Russian in RUB is up 13%. Feed prices in Q3 2023 were 261 EUR/T (compared to 332 EUR/T Q3 2022). End September 2023 on h
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®29.11.2023 10:00:00 CET | Press release
The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary endpoint Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study, which assessed the pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi in healthy adult subjects, met its primary endpoints. “These results demonstrate the strength of our platform approach to biosimilars development and manufacture, combining a well-designed and executed clinical study with the design of a high-quality manufacturing process and strong analytical capabilities,” said Joseph McClellan, Chief Scientific Officer. “As we progress more biosimilar candidates through clinical development and approval, w
The notes bought back by Municipality Finance will be removed from trading at Nasdaq Helsinki29.11.2023 10:00:00 CET | Press release
Municipality Finance Plc Stock exchange release 29 November 2023 at 11:00 am (EET) The notes bought back by Municipality Finance will be removed from trading at Nasdaq Helsinki On 27 November 2023 Municipality Finance Plc announced that it has bought back its EUR 10 million notes (ISIN XS2485560481) in whole. Nasdaq Helsinki has today approved MuniFin’s application to remove the notes from trading. MUNICIPALITY FINANCE PLC Further information: Joakim Holmström Executive Vice President, Capital Markets and Sustainability tel. +358 50 444 3638 MuniFin (Municipality Finance Plc) is one of Finland’s largest credit institutions. The owners of the company include Finnish municipalities, the public sector pension fund Keva and the Republic of Finland. MuniFin Group also includes the subsidiary company, Financial Advisory Services Inspira Ltd. The Group’s balance sheet totals approximately EUR 48 billion. MuniFin builds a better and more sustainable future with its customers. Our customers inc
Investeringsforeningen PortfolioManager - anmodning om suspension i afdeling29.11.2023 09:44:09 CET | pressemeddelelse
Pga. tekniske udfordringer har Investeringsforeningen PortfolioManager anmodet om suspension med handel af følgende afdelinger/andelsklasser: Afdelinger/andelsklasser i Investeringsforeningen PortfolioManagerFondskodeShortnameAI Alpha Lab Globale Aktier, kl nDK0062612644PMIAAN Suspensionen vil blive ophævet, når de tekniske udfordringer er løst, og det igen er muligt at stille priser. Eventuel henvendelse vedrørende denne meddelelse kan rettes til undertegnede på tlf. 38 42 21 42. Med venlig hilsen Nina Trolle Boldt, adm. direktør Fundmarket A/S